Neuropsychiatric manifestations of human leukocyte interferon therapy in patients with cancer

F. Adams, J. R. Quesada and J. U. Gutterman

The conditions of ten patients with metastatic renal cell carcinoma were serially evaluated by neuropsychiatric examination to determine the nature of the fatigue-asthenia symptoms resulting from human leukocyte interferon alpha therapy. The majority of the patients had moderate to severe behavioral changes and mild to moderate cognitive, affective, and personality changes within the first week of daily intramuscular administration of 3 X 10(6) units of interferon. This descriptive clinical study suggests that the intense fatigue may be a manifestation of a complex neurotoxicity, most suggestive of frontal lobe changes, and resulting in neurasthenia syndrome with reversible impairment of some higher mental functions.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Anti-depressant use in association with interferon and glatiramer acetate treatment in multiple sclerosis
Patten et al.
Mult Scler 2008;14:406-411.
ABSTRACT  

Hepatitis C treatment for people with severe mental illness.
Mistler et al.
Psychosomatics 2006;47:93-107.
ABSTRACT | FULL TEXT  

Association Between Apolipoprotein E {epsilon}4 and Neuropsychiatric Symptoms During Interferon {alpha} Treatment for Chronic Hepatitis C
Gochee et al.
Psychosomatics 2004;45:49-57.
ABSTRACT | FULL TEXT  

Recombinant interferon-{alpha}-induced chorea and frontal subcortical dementia
Gilbert et al.
Neurology 2002;59:1821-1821.
FULL TEXT  

Fatigue and Proinflammatory Cytokine Activity in Breast Cancer Survivors
Bower et al.
Psychosom. Med. 2002;64:604-611.
ABSTRACT | FULL TEXT  

Prophylactic Treatment of Depression Induced by Interferon-{{alpha}}
Hauser et al.
Psychosomatics 2000;41:439-441.
FULL TEXT  

Delirium With Autoimmune Thyroiditis Induced by Interferon Alpha
NIBUYA et al.
Am. J. Psychiatry 2000;157:1705-1707.
FULL TEXT  

Psychiatric Side Effects of Interferon Therapy: Prevalence, Proposed Mechanisms, and Future Directions
Trask et al.
JCO 2000;18:2316-2326.
ABSTRACT | FULL TEXT  

Neuropsychiatric Symptoms Associated With Hepatitis C and Interferon Alpha: A Review
Dieperink et al.
Am. J. Psychiatry 2000;157:867-876.
ABSTRACT | FULL TEXT  

Risk Factors for Severe Neuropsychiatric Toxicity in Patients Receiving Interferon Alfa-2b and Low-Dose Cytarabine for Chronic Myelogenous Leukemia: Analysis of Cancer and Leukemia Group B 9013
Hensley et al.
JCO 2000;18:1301-1308.
ABSTRACT | FULL TEXT  

Neurological Function During Long-Term Therapy With Recombinant Interferon Alpha
Mayr et al.
J. Neuropsychiatry Clin. Neurosi. 1999;11:343-348.
ABSTRACT | FULL TEXT  

Interferon Treatment of Hepatitis C Associated With Symptoms of PTSD
Maunder et al.
Psychosomatics 1998;39:461-464.
FULL TEXT  

Coincidental Changes in Behavior and Plasma Cortisol in Unrestrained Pigs after Intracerebroventricular Injection of Tumor Necrosis Factor-{alpha}
Warren et al.
Endocrinology 1997;138:2365-2371.
ABSTRACT | FULL TEXT  

The effects and after-effects of interferon alpha on human performance, mood and physiological functions
Smith et al.
J Psychopharmacol 1991;5:243-250.
ABSTRACT